Home-Based Monitoring Could Transform Care for Patients Receiving T-Cell Redirecting Therapies - Takeaways - MDSpire

Home-Based Monitoring Could Transform Care for Patients Receiving T-Cell Redirecting Therapies

A study found that outpatient observation cut hospital stays dramatically, with no adverse safety events reported. It also freed up inpatient beds and cut healthcare costs.

  • By

  • January 9, 2026

  • 4 min

Share

  • 1

    Outpatient monitoring for T-cell redirecting therapies significantly reduced hospital stays without adverse safety events.

  • 2

    Fox Chase implemented a pilot program that allowed most patients with relapsed lymphoma and multiple myeloma to receive outpatient therapy.

  • 3

    More than half of patients in the BiTE program avoided hospitalization entirely, showcasing the effectiveness of the outpatient model.

  • 4

    The outpatient approach optimizes healthcare resources by decreasing hospital admissions and costs while minimizing patient disruption.

  • 5

    The study emphasizes the importance of caregiver support and communication in ensuring patient safety during home monitoring.

Original Source(s)

Home-Based Monitoring Could Transform Care for Patients Receiving T-Cell Redirecting Therapies

  • by

  • January 9, 2026

Related Content

Blocking CD30 on CD19 CAR T cells augments their functional capacities against B-cell leukemia/lymphoma

HDAC7 controls anti-viral and anti-tumor immunity by CD8+ T cells

Combination of Lisaftoclax, Ixazomib, and Dexamethasone for Maintenance Therapy Following CAR-T in Patients with Transplant-Ineligible Relapsed/Refractory Ultra-High-Risk Multiple Myeloma: A Review of Two Cases and Relevant Literature